Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katsuyuki Karasawa

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 3, 2003
[Prostate cancer]Katsuyuki Karasawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 7, 2014
[The role of radiation therapy for rectal cancer: recent trend]Katsuyuki Karasawa
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 18, 2015
[Cancer therapy using unsealed radioisotopes-the present and future]Katsuyuki Karasawa
Anticancer Research|July 28, 2004
Ten-year disease-free survival of a small cell lung cancer patient with brain metastasis treated with chemoradiotherapyYuzuru Niibe, Katsuyuki Karasawa, Kazushige Hayakawa
Japanese Journal of Clinical Oncology|December 22, 2018
Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapyKei Ito, Takuya Shimizuguchi, Katsuyuki Karasawa
World Neurosurgery|March 5, 2022
Clinical Outcomes and Prognostic Factors of Fractionated Stereotactic Radiosurgery for Brain Metastases ≥20 mm as a Potential Alternative to SurgeryHiroaki Ogawa, Kei Ito, Katsuyuki Karasawa
Japanese Journal of Clinical Oncology|November 5, 2003
Hyperfractionated radiation therapy for hypopharyngeal carcinoma compared with conventional radiation therapy: local control, laryngeal preservation and overall survivalYuzuru Niibe, Katsuyuki Karasawa, Toshio Mitsuhashi, et al.
Japanese Journal of Clinical Oncology|December 1, 2017
Clinical outcomes and prognostic factors of chemoradiotherapy for postoperative lymph node recurrence of esophageal cancerTerufumi Kawamoto, Keiji Nihei, Keisuke Sasai, et al.
Japanese Journal of Clinical Oncology|December 8, 2022
Accelerated hypofractionated radiotherapy with 3 Gy per fraction for central/ultra-central lung tumors: toxicity to mediastinal organsKei Ito, Shota Minakami, Yujiro Nakajima, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 19, 2018
Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancerTerufumi Kawamoto, Keiji Nihei, Keisuke Sasai, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 3, 2003
[Prostate cancer]Katsuyuki Karasawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 7, 2014
[The role of radiation therapy for rectal cancer: recent trend]Katsuyuki Karasawa
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 18, 2015
[Cancer therapy using unsealed radioisotopes-the present and future]Katsuyuki Karasawa
Anticancer Research|July 28, 2004
Ten-year disease-free survival of a small cell lung cancer patient with brain metastasis treated with chemoradiotherapyYuzuru Niibe, Katsuyuki Karasawa, Kazushige Hayakawa
Japanese Journal of Clinical Oncology|December 22, 2018
Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapyKei Ito, Takuya Shimizuguchi, Katsuyuki Karasawa
World Neurosurgery|March 5, 2022
Clinical Outcomes and Prognostic Factors of Fractionated Stereotactic Radiosurgery for Brain Metastases ≥20 mm as a Potential Alternative to SurgeryHiroaki Ogawa, Kei Ito, Katsuyuki Karasawa
Japanese Journal of Clinical Oncology|November 5, 2003
Hyperfractionated radiation therapy for hypopharyngeal carcinoma compared with conventional radiation therapy: local control, laryngeal preservation and overall survivalYuzuru Niibe, Katsuyuki Karasawa, Toshio Mitsuhashi, et al.
Japanese Journal of Clinical Oncology|December 1, 2017
Clinical outcomes and prognostic factors of chemoradiotherapy for postoperative lymph node recurrence of esophageal cancerTerufumi Kawamoto, Keiji Nihei, Keisuke Sasai, et al.
Japanese Journal of Clinical Oncology|December 8, 2022
Accelerated hypofractionated radiotherapy with 3 Gy per fraction for central/ultra-central lung tumors: toxicity to mediastinal organsKei Ito, Shota Minakami, Yujiro Nakajima, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 19, 2018
Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancerTerufumi Kawamoto, Keiji Nihei, Keisuke Sasai, et al.
Pageof 12